Clinical Trial Update: Combination of SBRT and Immunotherapy in Small Hepatocellular Carcinoma (HSBRT2402) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update exploring a combination of SBRT and immunotherapy for small hepatocellular carcinoma, currently recruiting (HSBRT2402).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: RECRUITING